For many biopharmas, it takes years of hard work to transition from being a clinical-stage drugmaker to a commercial one.
For Big Pharma, recent headlines out of China suggest multinational drugmakers are facing their share of challenges in the ...
Every year, Fierce’s pharma, biotech, and medtech teams come together to spotlight some of the fiercest women in life s | ...
Trump leans toward selecting surgeon and COVID mandate critic Martin Makary for top FDA job: reports
While president-elect Donald Trump has already made his leadership picks for the Department of Health and Human Services (HHS ...
As a council of outside experts prepares to meet Thursday to discuss AstraZeneca’s Andexxa, the FDA has flagged “major safety ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback